CUL4B and lung carcinoma: The present study is therefore the first to report that CUL4B is an anti-apoptosis molecule, which occurs partially through activation of the ERK signaling pathway and phosphorylation of FOXO3A in lung cancer (the whole pathway is summarized in Figure 8).